An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
Gauthier JM, Hachem RR, Kreisel D. Update on Chronic Lung Allograft Dysfunction. Curr Transplant Rep (2016) 3:185–91. 10.1007/s40472-016-0112-y
-
DOI
-
PMC
-
PubMed
Girnita AL, Duquesnoy R, Yousem SA, Iacono AT, Corcoran TE, Buzoianu M, et al. HLA-Specific Antibodies Are Risk Factors for Lymphocytic Bronchiolitis and Chronic Lung Allograft Dysfunction. Am J Transplant (2005) 5:131–8. 10.1111/j.1600-6143.2004.00650.x
-
DOI
-
PubMed
Bray RA, Gebel HM, Townsend R, Roberts ME, Polinsky M, Yang L, et al. De Novo Donor-Specific Antibodies in Belatacept-Treated vs Cyclosporine-Treated Kidney-Transplant Recipients: Post Hoc Analyses of the Randomized Phase III BENEFIT and BENEFIT-EXT Studies. Am J Transplant (2018) 18:1783–9. 10.1111/ajt.14721
-
DOI
-
PMC
-
PubMed
Huang HJ, Schechtman K, Askar M, Bernadt C, Mitter B, Dore P, et al. A Pilot Randomized Controlled Trial of De Novo Belatacept-Based Immunosuppression After Lung Transplantation. Transplantation (2023) [Epub ahead of print]. 10.1097/TP.0000000000004841
-
DOI
-
PMC
-
PubMed
Iasella CJ, Winstead RJ, Moore CA, Johnson BA, Feinberg AT, Morrell MR, et al. Maintenance Belatacept-Based Immunosuppression in Lung Transplantation Recipients Who Failed Calcineurin Inhibitors. Transplantation (2018) 102:171–7. 10.1097/TP.0000000000001873
-
DOI
-
PubMed